Header Ads

Qualcomm ask china court to ban iPhone XS and XR sale

Qualcomm

Chipmaker Qualcomm is asking courts in China to ban sales of Apple's latest iPhone models iPhone XS and iPhone XR after winning a preliminary injunction against older models, the company confirmed on Thursday.

On Monday, a Chinese court had ordered a sales ban of some older Apple iPhone models for violating two patents of Qualcomm, though intellectual property lawyers said enforcement of the ban was likely still a distant threat.

"We plan to use the same patents to file suit against the three new iPhone models," Jiang Hongyi, a lawyer at Lexfield Law Offices who is representing Qualcomm in its patent suits, told the FT, which first reported the news on Thursday.

The case, brought by Qualcomm, is part of a global patent dispute between the two US companies that includes dozens of lawsuits.

Apple said on Monday that all of its phone models remained on sale in mainland China and that it had filed a request for reconsideration with the court, the first step in a long appeal process that could end up at China's Supreme Court.

Apple had also said its three models released in September were not part of the case. China, Hong Kong, and Taiwan accounted for about a fifth of Apple's $265.6 billion (roughly Rs. 19 lakh crores) in sales in its most recent fiscal year.

Qualcomm, the biggest supplier of chips for mobile phones, filed its case in China in late 2017, arguing that Apple infringed patents on features related to resizing photographs and managing apps on a touchscreen.

Apple responded by saying that "Qualcomm’s effort to ban our products is another desperate move by a company whose illegal practices are under investigation by regulators around the world."


Qualcomm officials said tensions between the two nations had no bearing on the ruling. The company has had its share of troubles in China, from an unfavorable 2014 antitrust ruling to regulatory limbo that doomed its $44 billion bid for Dutch chipmaker NXP Semiconductors. 

No comments

Powered by Blogger.